Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
101,287,986
-
Share change
-
+7,487,224
-
Total reported value
-
$431,527,258
-
Put/Call ratio
-
114%
-
Price per share
-
$4.26
-
Number of holders
-
124
-
Value change
-
+$26,967,129
-
Number of buys
-
72
-
Number of sells
-
52
Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q3 2014
As of 30 Sep 2014 OREXIGEN THERAPEUTICS INC - COM (OREX) had 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 101,287,986 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors, Partner Fund Management, L.P., State Street Corp, BlackRock Fund Advisors, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, NEA Management Company, LLC, and BlackRock Institutional Trust Company, N.A..
This table shows 124 institutional shareholders of the security as of 30 Sep 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.